Min Deng

Dr. Min Deng

Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cell Reports
Verified
Journal Article
Open access
XSXiaole Sheng
Xiaole Sheng
ZLZiguang Lin
Ziguang Lin
CLCong Lv
Cong Lv
CSChunlei Shao
Chunlei Shao
XBXueyun Bi
Xueyun Bi
ZYZhengquan Yu
Zhengquan Yu
A certain number of epithelial cells in intestinal crypts are DNA damage resistant and contribute to regeneration. However, the cellular mechanism underlying intestinal regeneration remains unclear. Using lineage tracing, we show that cells marked by an Msi1 reporter (Msi1+) are right above Lgr5high cells in intestinal crypts and exhibit DNA damage resistance. Single-cell RNA sequencing reveals that the Msi1+ cells are heterogeneous with the majority being intestinal stem cells (ISCs). The DNA damage-resistant subpopulation of Msi1+ cells is characterized by low-to-negative Lgr5 expression and is more rapidly cycling than Lgr5high radiosensitive crypt base columnar stem cells (CBCs). This enables an efficient repopulation of the intestinal epithelium at early stage when Lgr5high cells are not emerging. Furthermore, relative to CBCs, Msi1+ cells preferentially produce Paneth cells during homeostasis and upon radiation repair. Together, we demonstrate that the DNA damage-resistant Msi1+ cells are cycling ISCs that maintain and regenerate the intestinal epithelium.

4 March 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JXJiuzhi Xu
Jiuzhi Xu
YTYang Tang
Yang Tang
XSXiaole Sheng
Xiaole Sheng
YTYuhua Tian
Yuhua Tian
Min DengMin Deng
Min Deng
ZYZhengquan Yu
Zhengquan Yu
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

29 December 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
XYXu Yang
Xu Yang
GLGuilin Li
Guilin Li
PLPengbo Lou
Pengbo Lou
MZMingxin Zhang
Mingxin Zhang
KYKai Yao
Kai Yao
CLCong Lv
Cong Lv
Oxidative stress, which can be activated by a variety of environmental risk factors, has been implicated as an important pathogenic factor for inflammatory bowel disease (IBD). However, how oxidative stress drives IBD onset remains elusive. Here, we found that oxidative stress was strongly activated in inflamed tissues from both ulcerative colitis patients and Crohn’s disease patients, and it caused nuclear-to-cytosolic TDP-43 transport and a reduction in the TDP-43 protein level. To investigate the function of TDP-43 in IBD, we inducibly deleted exons 2 to 3 of Tardbp (encoding Tdp-43) in mouse intestinal epithelium, which disrupted its nuclear localization and RNA-processing function. The deletion gave rise to spontaneous intestinal inflammation by inducing epithelial cell necroptosis. Suppression of the necroptotic pathway with deletion of Mlkl or the RIP1 inhibitor Nec-1 rescued colitis phenotypes. Mechanistically, disruption of nuclear TDP-43 caused excessive R-loop accumulation, which triggered DNA damage and genome instability and thereby induced PARP1 hyperactivation, leading to subsequent NAD + depletion and ATP loss, consequently activating mitochondrion-dependent necroptosis in intestinal epithelial cells. Importantly, restoration of cellular NAD + levels with NAD + or NMN supplementation, as well as suppression of ALKBH7, an α-ketoglutarate dioxygenase in mitochondria, rescued TDP-43 deficiency-induced cell death and intestinal inflammation. Furthermore, TDP-43 protein levels were significantly inversely correlated with γ-H2A.X and p-MLKL levels in clinical IBD samples, suggesting the clinical relevance of TDP-43 deficiency-induced mitochondrion-dependent necroptosis. Taken together, these findings identify a unique pathogenic mechanism that links oxidative stress to intestinal inflammation and provide a potent and valid strategy for IBD intervention.

26 May 2020 in Cell Research
Verified
Journal Article
Closed access
PDF file
YSYongli Song
Yongli Song
CGChristian F. Guerrero-Juarez
Christian F. Guerrero-Juarez
ZCZhongjian Chen
Zhongjian Chen
YTYichen Tang
Yichen Tang
XMXianghui Ma
Xianghui Ma
ZYZhengquan Yu
Zhengquan Yu

21 June 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
XBXueyun Bi
Xueyun Bi
PLPengbo Lou
Pengbo Lou
SYSong Yong-li
Song Yong-li
XSXiaole Sheng
Xiaole Sheng
RLRuiqi Liu
Ruiqi Liu
ZYZhengquan Yu
Zhengquan Yu

16 March 2022 in Cell Research
Verified
Journal Article
Open access
PDF file
Min DengMin Deng
Min Deng
CGChristian F. Guerrero-Juarez
Christian F. Guerrero-Juarez
XSXiaole Sheng
Xiaole Sheng
JXJiuzhi Xu
Jiuzhi Xu
XWXi Wu
Xi Wu
CLCong Lv
Cong Lv
Diet can impact on gut health and disease by modulating intestinal stem cells (ISCs). However, it is largely unknown if and how the ISC niche responds to diet and influences ISC function. Here, we demonstrate that Lepr+ mesenchymal cells (MCs) surrounding intestinal crypts sense diet change and provide a novel niche signal to maintain ISC and progenitor cell proliferation. The abundance of these MCs increases upon administration of a high-fat diet (HFD) but dramatically decreases upon fasting. Depletion of Lepr+ MCs resulted in fewer intestinal stem/progenitor cells, compromised the architecture of crypt–villus axis and impaired intestinal regeneration. Furthermore, we showed that IGF1 secreted by Lepr+ MCs is an important effector that promotes proliferation of ISCs and progenitor cells in the intestinal crypt. We conclude that Lepr+ MCs sense diet alterations and, in turn, modulate intestinal stem/progenitor cell function via a stromal IGF1–epithelial IGF1R axis. These findings reveal that Lepr+ MCs are important mediators linking systemic diet changes to local ISC function and might serve as a novel therapeutic target for gut diseases.